Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era

TrAC - Trends in Analytical Chemistry

Volumn 76, Issue , 2016, Pages 86-94

  Wang, Xijun ^a   Zhang, Aihua ^a   Sun, Hui ^a   Han, Ying ^a   Yan, Guangli ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Chinmedomics; Liquid chromatography; Mass spectrometry; Metabolomics; Traditional medicine

Indexed keywords

BIOMARKERS; DRUG PRODUCTS; GENES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACODYNAMICS;

BIOLOGICAL PROPERTIES; CHINMEDOMICS; CLINICAL EXPERIENCE; COMPOUND STRUCTURES; HIGH-RESOLUTION METABOLOMICS; METABOLOMICS; PHARMACOLOGICAL ACTIVITY; SERUM PHARMACOCHEMISTRY;

DIAGNOSIS;

CHINESE DRUG; HERBACEOUS AGENT; UNCLASSIFIED DRUG; YINCHENHAO TANG;

CAPILLARY ELECTROPHORESIS; CHEMICAL COMPOSITION; CHINESE MEDICINE; CHINMEDOMICS; CLINICAL EFFECTIVENESS; DRUG DETERMINATION; DRUG FORMULATION; GAS CHROMATOGRAPHY; HUMAN; JAUNDICE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINAL PLANT; METABOLOMICS; NONHUMAN; PHYSICAL CHEMISTRY; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 84951082336     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2015.11.010     Document Type: Review

References (42)

1. Ajose F.O. Some Nigerian plants of dermatologic importance. Int. J. Dermatol 2007, 46:48-55.
2. Wang X., et al. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review. Am. J. Chin. Med 2012, 40:1109-1122.
3. Zhang E., Shen J., So K.F. Chinese traditional medicine and adult neurogenesis in the hippocampus. J. Tradit. Complement. Med 2014, 4:77-81.
4. Gu Y., Chen J., Shen J. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J. Neuroimmune. Pharmacol 2014, 9:313-339.
5. Sun H., Zhang A., Wang X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother. Res 2012, 26:1466-1471.
6. Wang X.J. Progress and future developing of the serum pharmacochemistry of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 2006, 31:789-792.
7. Clayton T.A., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
8. Wang X., et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J. Pharm. Biomed. Anal 2011, 55:859-868.
9. Zhang A., et al. Metabolomics: towards understanding traditional Chinese medicine. Planta Med 2010, 76:2026-2035.
10. Wang X., Zhang A., Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012, 16:414-421.
11. Zhang A., et al. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother. Res 2014, 28:526-533.
12. Zhang A., et al. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement. Ther. Med 2012, 20:93-99.
13. Liu X., et al. Pharmacological tools for the development of traditional Chinese medicine. Trends Pharmacol. Sci 2013, 34:620-628.
14. Zheng H., et al. From single target to multitarget/network therapeutics in Alzheimer's therapy. Pharmaceuticals (Basel) 2014, 7(2):113-135.
15. Sancineto L., et al. Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands. Bioorg. Med. Chem 2012, 22:4658-4666.
16. Dawson R., Diacon A. PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis. Expert Opin. Investig. Drugs 2013, 22:927-932.
17. Nicholson J.K., Lindon J.C. Systems biology: Metabonomics. Nature 2008, 455:1054-1056.
18. Dong H., et al. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol. Biosyst 2012, 8:1206-1221.
19. Zhang A., Sun H., Wang X. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 2013, 57:2072-2077.
20. Zhang A., Sun H., Wang X. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity. Sci. Rep 2014, 4:6768.
21. Wang X., et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol. Cell. Proteomics 2012, 11:380-381.
22. Zhang A., et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012, 137:4200-4208.
23. Zhang A., et al. Modern analytical techniques in metabolomics analysis. Analyst 2012, 137:293-300.
24. Zhang A.H., et al. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets. Anal. Chem 2013, 85:7606-7612.
25. Wang X., et al. Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal. Chem 2012, 84:439-442.
26. Zhang A., et al. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J. Sep. Sci 2014, 37(14):1742-1747.
27. Sun H., et al. Profiling and identification of the absorbed constituents and metabolites of schisandra lignans by ultra-performance liquid chromatography coupled to mass spectrometry. Biomed. Chromatogr 2013, 27:1511-1519.
28. Yan G.L., et al. An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach. J. Sep. Sci 2013, 36:3191-3199.
29. Zhang A., et al. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J. Sep. Sci 2014, 37:1742-1747.
30. Sun H., et al. Pharmacokinetics study of multiple components absorbed in rat plasma after oral administration of Stemonae radix using ultra-performance liquid-chromatography/mass spectrometry with automated MetaboLynx software analysis. J. Sep. Sci 2012, 35(24):3477-3485.
31. Wang X., et al. Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry combined with pattern recognition methods. Analyst 2011, 136:5068-5076.
32. Ying H., et al. Characterization of multiple constituents in rat plasma after oral administration of Shengmai San using ultra-performance liquid chromatography coupled with electrospray ionization/quadrupole-time-of-flight high-definition mass spectrometry. Anal. Method 2015, 7:830-837.
33. Liu C., et al. Ultra-high performance liquid chromatography coupled with time-of-flight mass spectrometry screening and analysis of potential bioactive compounds from traditional chinese medicine Kai-Xin-San, using a multivariate data processing approach and the MetaboLynx tool. RSC Advances 2015, 5:85.
34. Zhang A., et al. Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples. Biomed. Chromatogr 2012, 26:844-850.
35. Wang X., et al. Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. J. Pharm. Biomed. Anal 2008, 48:1161-1168.
36. Lee T.Y., et al. Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang. Int. J. Mol. Med 2009, 23:477-484.
37. Sun H., et al. Proteomics study on the hepatoprotective effects of traditional Chinese medicine formulae Yin-Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. J. Pharm. Biomed. Anal 2013, 75:173-179.
38. Lee T.Y., et al. Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis. Int. J. Mol. Med 2010, 25:837-844.
39. Wang X., et al. Quality evaluation of Yin Chen Hao Tang extract based on fingerprint chromatogram and simultaneous determination of five bioactive constituents. J. Sep. Sci 2008, 31:9-15.
40. Wang X., et al. Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS. J. Pharm. Biomed. Anal 2008, 46:477-490.
41. Wang X., et al. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol. Cell. Proteomics 2013, 12:1226-1238.
42. Zhang A., et al. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. Fitoterapia 2011, 82:1168-1176.